受体阻滞剂-话题@MedSci

#受体阻滞剂#

148篇内容 | 1332人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1995223, encodeId=f5a6199522326, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=JAHA：这类心衰患者入院使用 β 受体阻滞剂，可降低58%的院内死亡风险, objectType=article, longId=213832, objectId=518621383207, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=518621383207, replyNumber=0, likeNumber=35, createdTime=2021-09-20, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=518621383207, moduleTitle=JAHA：这类心衰患者入院使用 β 受体阻滞剂，可降低58%的院内死亡风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=518621383207)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995213, encodeId=418b199521317, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=J Am Coll Cardiol：肾功能损害对心力衰竭患者β-受体阻滞剂疗效的影响, objectType=article, longId=198014, objectId=79031980146c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=79031980146c, replyNumber=0, likeNumber=37, createdTime=2020-12-23, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=79031980146c, moduleTitle=J Am Coll Cardiol：肾功能损害对心力衰竭患者β-受体阻滞剂疗效的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=79031980146c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995211, encodeId=b0fe19952112a, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=Eur Heart J：无心衰急性心肌梗死患者长期β受体阻滞剂治疗的临床结局, objectType=article, longId=196010, objectId=c6ff19601043, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6ff19601043, replyNumber=0, likeNumber=35, createdTime=2020-06-21, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6ff19601043, moduleTitle=Eur Heart J：无心衰急性心肌梗死患者长期β受体阻滞剂治疗的临床结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c6ff19601043)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995215, encodeId=ad8a1995215e3, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=J Hepatology: β受体阻滞剂的短期血流动力学影响会对失代偿性肝硬化患者的生存产生负面作用, objectType=article, longId=201792, objectId=2c6d201e9206, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c6d201e9206, replyNumber=0, likeNumber=36, createdTime=2021-07-03, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c6d201e9206, moduleTitle=J Hepatology: β受体阻滞剂的短期血流动力学影响会对失代偿性肝硬化患者的生存产生负面作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2c6d201e9206)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995206, encodeId=2bad1995206cc, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=“BETA”原则：冠心病患者如何使用β受体阻滞剂, objectType=article, longId=189561, objectId=8390189561b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8390189561b2, replyNumber=0, likeNumber=44, createdTime=2020-12-21, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8390189561b2, moduleTitle=“BETA”原则：冠心病患者如何使用β受体阻滞剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8390189561b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995216, encodeId=484a1995216d3, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=JAHA：β受体阻滞剂治疗的阻塞性睡眠呼吸暂停综合症患者的夜间心律失常和心率波动, objectType=article, longId=202571, objectId=f9292025e160, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9292025e160, replyNumber=0, likeNumber=24, createdTime=2021-10-06, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9292025e160, moduleTitle=JAHA：β受体阻滞剂治疗的阻塞性睡眠呼吸暂停综合症患者的夜间心律失常和心率波动, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f9292025e160)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995212, encodeId=45e21995212de, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=Hypertension：血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂与较低的结直肠癌风险相关, objectType=article, longId=197196, objectId=31a819e19633, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=31a819e19633, replyNumber=0, likeNumber=35, createdTime=2021-05-09, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=31a819e19633, moduleTitle=Hypertension：血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂与较低的结直肠癌风险相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=31a819e19633)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995214, encodeId=edac19952140c, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=Heart：β受体阻滞剂在经皮冠状动脉介入治疗急性冠脉综合征患者中的作用, objectType=article, longId=200304, objectId=58642003043d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=58642003043d, replyNumber=0, likeNumber=41, createdTime=2021-01-25, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58642003043d, moduleTitle=Heart：β受体阻滞剂在经皮冠状动脉介入治疗急性冠脉综合征患者中的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=58642003043d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995209, encodeId=e65d199520937, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=Med Sci：提高β受体阻滞剂的剂量可减少与心力衰竭有关的住院和心律失常事件, objectType=article, longId=190425, objectId=b42d19042540, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b42d19042540, replyNumber=0, likeNumber=34, createdTime=2020-10-04, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b42d19042540, moduleTitle=Med Sci：提高β受体阻滞剂的剂量可减少与心力衰竭有关的住院和心律失常事件, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b42d19042540)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995205, encodeId=e9331995205b3, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=中国仅14.8%心衰患者出院时处方β受体阻滞剂！首次中国心衰医疗质量评估：出院时预约随访比例仅11.8%, objectType=article, longId=186169, objectId=d65f1861694f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d65f1861694f, replyNumber=0, likeNumber=29, createdTime=2020-12-23, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d65f1861694f, moduleTitle=中国仅14.8%心衰患者出院时处方β受体阻滞剂！首次中国心衰医疗质量评估：出院时预约随访比例仅11.8%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d65f1861694f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995202, encodeId=c64819952024c, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=Crit Care：发病前β受体阻滞剂暴露与脓毒症死亡率之间的关联, objectType=article, longId=179821, objectId=27381e98217d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27381e98217d, replyNumber=0, likeNumber=31, createdTime=2020-04-23, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27381e98217d, moduleTitle=Crit Care：发病前β受体阻滞剂暴露与脓毒症死亡率之间的关联, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=27381e98217d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995207, encodeId=9ddc199520eb1, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=J Hepatology：心功能，难治性腹水和β受体阻滞剂对肝硬化患者肝移植预后的影响, objectType=article, longId=190081, objectId=8a911900817c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a911900817c, replyNumber=0, likeNumber=45, createdTime=2020-11-23, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a911900817c, moduleTitle=J Hepatology：心功能，难治性腹水和β受体阻滞剂对肝硬化患者肝移植预后的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8a911900817c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995203, encodeId=890a1995203c6, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=JACC：β受体阻滞剂可降低心衰伴射血分数降低患者的死亡风险, objectType=article, longId=184381, objectId=81dd184381f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=81dd184381f4, replyNumber=0, likeNumber=41, createdTime=2020-05-20, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=81dd184381f4, moduleTitle=JACC：β受体阻滞剂可降低心衰伴射血分数降低患者的死亡风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=81dd184381f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995208, encodeId=adb4199520850, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=BMC Cardiovasc Disord：慢性心力衰竭和心房纤颤患者的β受体阻滞剂和全因死亡风险, objectType=article, longId=190417, objectId=8aca19041e2b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8aca19041e2b, replyNumber=0, likeNumber=17, createdTime=2020-06-20, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8aca19041e2b, moduleTitle=BMC Cardiovasc Disord：慢性心力衰竭和心房纤颤患者的β受体阻滞剂和全因死亡风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8aca19041e2b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995210, encodeId=1f65199521099, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=ACE抑制剂和血管紧张素受体阻滞剂（ARBs）可能增加罹患COVID-19的风险, objectType=article, longId=190727, objectId=788c190e27af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=788c190e27af, replyNumber=0, likeNumber=32, createdTime=2020-08-02, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=788c190e27af, moduleTitle=ACE抑制剂和血管紧张素受体阻滞剂（ARBs）可能增加罹患COVID-19的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=788c190e27af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995200, encodeId=4b00199520097, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=Hypertension：高龄女性使用α受体阻滞剂与低血压和相关临床事件风险, objectType=article, longId=176009, objectId=eefe1e6009d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eefe1e6009d3, replyNumber=0, likeNumber=39, createdTime=2020-04-09, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eefe1e6009d3, moduleTitle=Hypertension：高龄女性使用α受体阻滞剂与低血压和相关临床事件风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eefe1e6009d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995204, encodeId=30cb199520407, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=JAMA Netw Open:中国仅14.8%心衰患者出院时处方β受体阻滞剂！首次中国心衰医疗质量评估：出院时预约随访比例仅11.8%, objectType=article, longId=186120, objectId=462318612022, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=462318612022, replyNumber=0, likeNumber=29, createdTime=2020-06-11, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=462318612022, moduleTitle=JAMA Netw Open:中国仅14.8%心衰患者出院时处方β受体阻滞剂！首次中国心衰医疗质量评估：出院时预约随访比例仅11.8%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=462318612022)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995197, encodeId=0f3e199519e99, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=β受体阻滞剂在高血压应用中的专家共识, objectType=article, longId=165739, objectId=3a78165e3980, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a78165e3980, replyNumber=0, likeNumber=22, createdTime=2019-06-10, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a78165e3980, moduleTitle=β受体阻滞剂在高血压应用中的专家共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a78165e3980)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995195, encodeId=9108199519548, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=AP&T：非选择性β受体阻滞剂增加肝硬化患者门静脉血栓形成的概率, objectType=article, longId=160232, objectId=cfc5160232ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cfc5160232ec, replyNumber=0, likeNumber=0, createdTime=2019-10-18, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cfc5160232ec, moduleTitle=AP&T：非选择性β受体阻滞剂增加肝硬化患者门静脉血栓形成的概率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cfc5160232ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1995193, encodeId=a309199519305, content=<a href='/topic/show?id=347538040cf' target=_blank style='color:#2F92EE;'>#受体阻滞剂#</a>, objectTitle=Clin Res Cardiol：β受体阻滞剂与慢性心力衰竭——达到“目标剂量”还是“目标心率”？, objectType=article, longId=154613, objectId=fd541546136d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd541546136d, replyNumber=0, likeNumber=31, createdTime=2019-01-03, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd541546136d, moduleTitle=Clin Res Cardiol：β受体阻滞剂与慢性心力衰竭——达到“目标剂量”还是“目标心率”？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd541546136d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

受体阻滞剂

2020-05-29

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

JAHA：这类心衰患者入院使用 β 受体阻滞剂，可降低58%的院内死亡风险

2021-09-20

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

J Am Coll Cardiol：肾功能损害对心力衰竭患者β-受体阻滞剂疗效的影响

2020-12-23

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

Eur Heart J：无心衰急性心肌梗死患者长期β受体阻滞剂治疗的临床结局

2020-06-21

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

J Hepatology: β受体阻滞剂的短期血流动力学影响会对失代偿性肝硬化患者的生存产生负面作用

2021-07-03

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

“BETA”原则：冠心病患者如何使用β受体阻滞剂

2020-12-21

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

JAHA：β受体阻滞剂治疗的阻塞性睡眠呼吸暂停综合症患者的夜间心律失常和心率波动

2021-10-06

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

Hypertension：血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂与较低的结直肠癌风险相关

2021-05-09

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

Heart：β受体阻滞剂在经皮冠状动脉介入治疗急性冠脉综合征患者中的作用

2021-01-25

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

Med Sci：提高β受体阻滞剂的剂量可减少与心力衰竭有关的住院和心律失常事件

2020-10-04

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

中国仅14.8%心衰患者出院时处方β受体阻滞剂！首次中国心衰医疗质量评估：出院时预约随访比例仅11.8%

2020-12-23

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

Crit Care：发病前β受体阻滞剂暴露与脓毒症死亡率之间的关联

2020-04-23

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

J Hepatology：心功能，难治性腹水和β受体阻滞剂对肝硬化患者肝移植预后的影响

2020-11-23

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

JACC：β受体阻滞剂可降低心衰伴射血分数降低患者的死亡风险

2020-05-20

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

BMC Cardiovasc Disord：慢性心力衰竭和心房纤颤患者的β受体阻滞剂和全因死亡风险

2020-06-20

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

ACE抑制剂和血管紧张素受体阻滞剂（ARBs）可能增加罹患COVID-19的风险

2020-08-02

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

Hypertension：高龄女性使用α受体阻滞剂与低血压和相关临床事件风险

2020-04-09

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

JAMA Netw Open:中国仅14.8%心衰患者出院时处方β受体阻滞剂！首次中国心衰医疗质量评估：出院时预约随访比例仅11.8%

2020-06-11

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

β受体阻滞剂在高血压应用中的专家共识

2019-06-10

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

AP&T：非选择性β受体阻滞剂增加肝硬化患者门静脉血栓形成的概率

2019-10-18

tulenzi (审核中...)

前往app查看评论内容

#受体阻滞剂#

Clin Res Cardiol：β受体阻滞剂与慢性心力衰竭——达到“目标剂量”还是“目标心率”？

2019-01-03

科室
- - 订阅+
  - 更多科室
工具
服务